William Kim, MD
Rheumatology · Las Vegas, NVNPI 1407829385
Payments from drug & device makers
Across 624 payments — averaging $292.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$89K
- Janssen Research & Development, LLC$78K
- AbbVie$6K
- Amgen$2K
- UCB, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$905
- plus $6K from 28 others
What the payments were for
- Consulting fees$1001%
- Food & beverage$15,99399%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 46 | $88,839 |
| Janssen Research & Development, LLC | 12 | $77,632 |
| AbbVie | 138 | $5,841 |
| Amgen(2 entities) | 61 | $1,855 |
| UCB, Inc. | 59 | $1,181 |
| E.r. Squibb & Sons, L.L.C. | 70 | $905 |
| Biogen | 1 | $855 |
| Novartis | 26 | $593 |
| Johnson & Johnson | 46 | $552 |
| Janssen Scientific Affairs, LLC | 6 | $519 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 51 | $494 |
| GSK | 22 | $437 |
| Sanofi | 5 | $425 |
| Lilly USA, LLC | 18 | $388 |
| Genentech USA, Inc. | 13 | $374 |
| AstraZeneca(2 entities) | 4 | $292 |
| Boehringer Ingelheim | 7 | $246 |
| Mallinckrodt Hospital Products Inc. | 9 | $222 |
| Radius Health, Inc. | 3 | $157 |
| Nevro Corp. | 1 | $138 |
| ANI Pharmaceuticals, Inc. | 1 | $125 |
| Aurinia Pharma U.S., Inc. | 1 | $122 |
| Cardinal Health 110 LLC | 1 | $100 |
| Scilex Pharmaceuticals Inc. | 5 | $96 |
| Mallinckrodt Enterprises LLC | 3 | $68 |
| IBSA Pharma Inc. | 3 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Bristol Myers Squibb | 2 | $35 |
| Merck | 2 | $31 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Sobi, Inc | 1 | $13 |
| Organon | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$182,720 in reported general payments places this provider in the 85th percentile of 43 rheumatology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 11 | $73,518 |
| Pregabalin | 18 | $751 |
| MethotrexateMethotrexate Sodium | 27 | $491 |
| Prednisone | 40 | $172 |
| Leucovorin Calcium | 17 | $46 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Las Vegas
- Sandra PagnussatLas Vegas$28.3M
- Walter ChathamLas Vegas$2.2M
- George KellyLas Vegas$1.1M
- Ewa OlechLas Vegas$297K
- Nasim DaoudLas Vegas$109K
- Aida LoudyiLas Vegas$10K
- Tudor JianuLas Vegas$8K
- Khalil Ibrahim BourjiLas Vegas$7K
- Neil BraunsteinLas Vegas$6K
- Michael CliffordLas Vegas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.